Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001037389-21-000052
Filing Date
2021-02-10
Accepted
2021-02-10 13:45:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 abio-13g_20201231.txt SC 13G/A 11749
  Complete submission text file 0001037389-21-000052.txt   13513
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 21612919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 800 THIRD AVE NEW YORK NY 10022
Business Address 800 THIRD AVE NEW YORK NY 10022 2124866780
RENAISSANCE TECHNOLOGIES LLC (Filed by) CIK: 0001037389 (see all company filings)

EIN.: 260385758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A